Concepts (354)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Tissue Engineering | 56 | 2023 | 656 | 7.400 |
Why?
|
| Tissue Scaffolds | 45 | 2023 | 415 | 7.150 |
Why?
|
| Regeneration | 9 | 2023 | 170 | 2.530 |
Why?
|
| Muscle, Skeletal | 10 | 2020 | 518 | 2.150 |
Why?
|
| Collagen | 15 | 2020 | 225 | 2.140 |
Why?
|
| Polyesters | 16 | 2019 | 76 | 2.100 |
Why?
|
| Extracellular Matrix | 12 | 2023 | 245 | 1.960 |
Why?
|
| Biocompatible Materials | 19 | 2023 | 232 | 1.800 |
Why?
|
| Animals | 61 | 2023 | 7459 | 1.730 |
Why?
|
| Hydrogels | 12 | 2020 | 121 | 1.680 |
Why?
|
| Bioprosthesis | 4 | 2023 | 58 | 1.650 |
Why?
|
| Blood Vessel Prosthesis | 9 | 2023 | 83 | 1.630 |
Why?
|
| Stem Cells | 10 | 2020 | 313 | 1.600 |
Why?
|
| Myocytes, Smooth Muscle | 6 | 2017 | 72 | 1.520 |
Why?
|
| Ear Cartilage | 4 | 2021 | 12 | 1.470 |
Why?
|
| Gelatin | 6 | 2019 | 29 | 1.430 |
Why?
|
| Myoblasts, Skeletal | 2 | 2020 | 19 | 1.380 |
Why?
|
| Guided Tissue Regeneration | 6 | 2020 | 38 | 1.320 |
Why?
|
| Troponin I | 4 | 2021 | 22 | 1.260 |
Why?
|
| Materials Testing | 10 | 2018 | 89 | 1.190 |
Why?
|
| Alginates | 3 | 2023 | 53 | 1.090 |
Why?
|
| Cell Differentiation | 12 | 2020 | 468 | 1.040 |
Why?
|
| Microscopy, Electron, Scanning | 18 | 2020 | 98 | 1.010 |
Why?
|
| Amniotic Fluid | 7 | 2019 | 86 | 0.980 |
Why?
|
| Postoperative Complications | 2 | 2020 | 784 | 0.970 |
Why?
|
| Polyglactin 910 | 2 | 2019 | 6 | 0.970 |
Why?
|
| Cell Proliferation | 16 | 2020 | 598 | 0.960 |
Why?
|
| Cells, Cultured | 18 | 2019 | 833 | 0.930 |
Why?
|
| Lactic Acid | 7 | 2014 | 53 | 0.890 |
Why?
|
| Surgical Procedures, Operative | 2 | 2021 | 82 | 0.880 |
Why?
|
| Drug Delivery Systems | 3 | 2013 | 104 | 0.870 |
Why?
|
| Wound Healing | 6 | 2023 | 185 | 0.870 |
Why?
|
| Polymers | 5 | 2016 | 64 | 0.830 |
Why?
|
| Coronary Artery Bypass | 2 | 2020 | 101 | 0.830 |
Why?
|
| Rats | 14 | 2020 | 1592 | 0.790 |
Why?
|
| Humans | 47 | 2023 | 31976 | 0.770 |
Why?
|
| Reperfusion Injury | 2 | 2020 | 49 | 0.750 |
Why?
|
| Swine | 11 | 2023 | 215 | 0.740 |
Why?
|
| Cell Survival | 11 | 2020 | 285 | 0.730 |
Why?
|
| Blood Vessels | 3 | 2010 | 49 | 0.720 |
Why?
|
| Muscular Diseases | 1 | 2020 | 22 | 0.700 |
Why?
|
| Ink | 2 | 2019 | 11 | 0.700 |
Why?
|
| Cardiomyopathies | 1 | 2020 | 55 | 0.700 |
Why?
|
| Hospital Mortality | 2 | 2020 | 198 | 0.700 |
Why?
|
| Nanofibers | 1 | 2019 | 5 | 0.700 |
Why?
|
| Heart Diseases | 1 | 2021 | 116 | 0.690 |
Why?
|
| Kidney | 4 | 2022 | 515 | 0.690 |
Why?
|
| Skin Transplantation | 2 | 2023 | 49 | 0.630 |
Why?
|
| Mice | 22 | 2023 | 2472 | 0.610 |
Why?
|
| Kidney Glomerulus | 1 | 2018 | 30 | 0.600 |
Why?
|
| Muscle, Smooth, Vascular | 2 | 2017 | 63 | 0.600 |
Why?
|
| Stem Cell Transplantation | 3 | 2019 | 209 | 0.600 |
Why?
|
| Body Mass Index | 1 | 2021 | 922 | 0.590 |
Why?
|
| Acute Coronary Syndrome | 1 | 2019 | 196 | 0.590 |
Why?
|
| Neurons | 2 | 2020 | 409 | 0.580 |
Why?
|
| Bone Regeneration | 4 | 2020 | 32 | 0.580 |
Why?
|
| Cell Adhesion | 12 | 2012 | 108 | 0.580 |
Why?
|
| Regenerative Medicine | 3 | 2019 | 201 | 0.560 |
Why?
|
| Burns | 1 | 2017 | 100 | 0.540 |
Why?
|
| Osteogenesis | 7 | 2020 | 82 | 0.520 |
Why?
|
| Tensile Strength | 9 | 2018 | 53 | 0.520 |
Why?
|
| Cardiovascular Diseases | 1 | 2023 | 1125 | 0.510 |
Why?
|
| Osteoblasts | 2 | 2006 | 45 | 0.510 |
Why?
|
| RNA | 1 | 2015 | 91 | 0.500 |
Why?
|
| Kidney Diseases | 1 | 2018 | 249 | 0.500 |
Why?
|
| Heparin | 2 | 2012 | 74 | 0.500 |
Why?
|
| Cells, Immobilized | 2 | 2014 | 23 | 0.500 |
Why?
|
| Rabbits | 7 | 2019 | 196 | 0.490 |
Why?
|
| Satellite Cells, Skeletal Muscle | 1 | 2014 | 8 | 0.480 |
Why?
|
| Prostheses and Implants | 2 | 2014 | 42 | 0.480 |
Why?
|
| Muscle Fibers, Skeletal | 6 | 2019 | 109 | 0.480 |
Why?
|
| Chondrocytes | 5 | 2018 | 74 | 0.470 |
Why?
|
| Cell Culture Techniques | 7 | 2016 | 173 | 0.450 |
Why?
|
| Fibrin | 1 | 2013 | 6 | 0.440 |
Why?
|
| Obesity | 1 | 2021 | 1176 | 0.440 |
Why?
|
| Rheology | 5 | 2019 | 30 | 0.430 |
Why?
|
| Trachea | 3 | 2019 | 53 | 0.430 |
Why?
|
| Proto-Oncogene Proteins c-sis | 1 | 2012 | 9 | 0.420 |
Why?
|
| Muramidase | 1 | 2012 | 8 | 0.410 |
Why?
|
| Time Factors | 6 | 2021 | 2150 | 0.400 |
Why?
|
| Proteins | 1 | 2013 | 144 | 0.400 |
Why?
|
| Substance P | 1 | 2011 | 20 | 0.400 |
Why?
|
| Chemokine CXCL12 | 1 | 2011 | 25 | 0.400 |
Why?
|
| Male | 18 | 2021 | 19155 | 0.400 |
Why?
|
| Nanostructures | 2 | 2008 | 19 | 0.380 |
Why?
|
| Muscle Development | 3 | 2019 | 49 | 0.370 |
Why?
|
| Endothelial Cells | 5 | 2014 | 189 | 0.350 |
Why?
|
| Skin | 2 | 2023 | 210 | 0.350 |
Why?
|
| Absorbable Implants | 2 | 2013 | 24 | 0.340 |
Why?
|
| Mesenchymal Stem Cells | 4 | 2019 | 182 | 0.340 |
Why?
|
| Polyglycolic Acid | 5 | 2013 | 33 | 0.330 |
Why?
|
| Neurites | 2 | 2013 | 10 | 0.330 |
Why?
|
| Transplantation | 1 | 2008 | 13 | 0.320 |
Why?
|
| Cattle | 6 | 2015 | 103 | 0.310 |
Why?
|
| Porosity | 6 | 2018 | 38 | 0.300 |
Why?
|
| Feasibility Studies | 2 | 2020 | 292 | 0.300 |
Why?
|
| Glycolates | 2 | 2005 | 7 | 0.300 |
Why?
|
| Intestine, Small | 2 | 2006 | 40 | 0.290 |
Why?
|
| Cell Line | 9 | 2019 | 435 | 0.290 |
Why?
|
| Intestinal Mucosa | 2 | 2006 | 71 | 0.290 |
Why?
|
| Polycarboxylate Cement | 2 | 2004 | 2 | 0.290 |
Why?
|
| Surface Properties | 6 | 2010 | 32 | 0.280 |
Why?
|
| Ear Auricle | 2 | 2018 | 5 | 0.280 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 1015 | 0.280 |
Why?
|
| Antigens, CD | 2 | 2018 | 103 | 0.270 |
Why?
|
| Neuromuscular Junction | 2 | 2020 | 72 | 0.270 |
Why?
|
| Female | 11 | 2021 | 19916 | 0.270 |
Why?
|
| Renal Insufficiency, Chronic | 2 | 2020 | 288 | 0.270 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 2 | 2019 | 104 | 0.260 |
Why?
|
| Bone Substitutes | 1 | 2004 | 9 | 0.240 |
Why?
|
| Cross-Linking Reagents | 3 | 2014 | 16 | 0.240 |
Why?
|
| Bone and Bones | 2 | 2004 | 94 | 0.230 |
Why?
|
| Immunohistochemistry | 2 | 2017 | 532 | 0.230 |
Why?
|
| Polyethylene | 1 | 2003 | 6 | 0.220 |
Why?
|
| Islets of Langerhans Transplantation | 1 | 2023 | 47 | 0.220 |
Why?
|
| Oxygen | 4 | 2022 | 142 | 0.220 |
Why?
|
| Islets of Langerhans | 1 | 2023 | 76 | 0.220 |
Why?
|
| Sheep | 4 | 2017 | 233 | 0.210 |
Why?
|
| Collagen Type I | 3 | 2013 | 42 | 0.210 |
Why?
|
| Nerve Regeneration | 2 | 2013 | 48 | 0.210 |
Why?
|
| Chlorates | 1 | 2002 | 1 | 0.200 |
Why?
|
| Tendons | 2 | 2013 | 59 | 0.200 |
Why?
|
| Viscosity | 2 | 2018 | 22 | 0.190 |
Why?
|
| Elasticity | 2 | 2018 | 36 | 0.190 |
Why?
|
| Kinetics | 3 | 2022 | 209 | 0.190 |
Why?
|
| Aged | 5 | 2021 | 10332 | 0.190 |
Why?
|
| Pregnancy | 3 | 2020 | 994 | 0.180 |
Why?
|
| Republic of Korea | 1 | 2020 | 12 | 0.180 |
Why?
|
| Rats, Inbred Lew | 3 | 2015 | 117 | 0.180 |
Why?
|
| Delayed-Action Preparations | 2 | 2012 | 34 | 0.180 |
Why?
|
| Adrenergic beta-Antagonists | 1 | 2020 | 61 | 0.180 |
Why?
|
| Biomimetic Materials | 1 | 2020 | 15 | 0.180 |
Why?
|
| Middle Aged | 5 | 2021 | 11845 | 0.180 |
Why?
|
| Secondary Prevention | 1 | 2020 | 63 | 0.180 |
Why?
|
| Acute Disease | 1 | 2020 | 253 | 0.170 |
Why?
|
| Registries | 1 | 2021 | 298 | 0.170 |
Why?
|
| ROC Curve | 1 | 2019 | 164 | 0.170 |
Why?
|
| Risk | 1 | 2020 | 319 | 0.170 |
Why?
|
| Mandibular Prosthesis | 1 | 2019 | 2 | 0.170 |
Why?
|
| Myocardial Ischemia | 1 | 2020 | 106 | 0.170 |
Why?
|
| Fibroblasts | 4 | 2020 | 110 | 0.170 |
Why?
|
| Calcium Phosphates | 1 | 2019 | 9 | 0.170 |
Why?
|
| Methacrylates | 1 | 2019 | 3 | 0.170 |
Why?
|
| Kidney Function Tests | 1 | 2019 | 106 | 0.160 |
Why?
|
| Thrombin | 2 | 2010 | 16 | 0.160 |
Why?
|
| Ultraviolet Rays | 1 | 2019 | 51 | 0.160 |
Why?
|
| Algorithms | 1 | 2022 | 496 | 0.160 |
Why?
|
| Mice, Inbred C57BL | 2 | 2018 | 765 | 0.160 |
Why?
|
| Nerve Net | 1 | 2020 | 123 | 0.160 |
Why?
|
| Chronic Disease | 1 | 2020 | 401 | 0.160 |
Why?
|
| Comorbidity | 1 | 2020 | 567 | 0.160 |
Why?
|
| Fibroins | 1 | 2018 | 5 | 0.160 |
Why?
|
| Odds Ratio | 1 | 2019 | 474 | 0.160 |
Why?
|
| Graft Survival | 2 | 2017 | 314 | 0.160 |
Why?
|
| Insulin-Like Growth Factor I | 2 | 2019 | 83 | 0.160 |
Why?
|
| Reconstructive Surgical Procedures | 2 | 2018 | 199 | 0.160 |
Why?
|
| Myoblasts | 2 | 2015 | 38 | 0.150 |
Why?
|
| Myocardial Contraction | 1 | 2018 | 64 | 0.150 |
Why?
|
| Myocytes, Cardiac | 1 | 2018 | 86 | 0.150 |
Why?
|
| Tissue Expansion Devices | 1 | 2017 | 10 | 0.150 |
Why?
|
| Cytokines | 1 | 2019 | 255 | 0.150 |
Why?
|
| Emergency Medical Services | 1 | 2019 | 178 | 0.140 |
Why?
|
| Cicatrix | 1 | 2017 | 39 | 0.140 |
Why?
|
| Bioartificial Organs | 2 | 2015 | 25 | 0.140 |
Why?
|
| Polyurethanes | 1 | 2016 | 5 | 0.140 |
Why?
|
| Myocardium | 1 | 2018 | 186 | 0.140 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2017 | 70 | 0.140 |
Why?
|
| NIH 3T3 Cells | 4 | 2011 | 43 | 0.140 |
Why?
|
| Ovarian Follicle | 1 | 2016 | 29 | 0.140 |
Why?
|
| Rats, Nude | 4 | 2020 | 43 | 0.140 |
Why?
|
| Spectroscopy, Near-Infrared | 2 | 2013 | 10 | 0.140 |
Why?
|
| Mice, Nude | 5 | 2020 | 290 | 0.140 |
Why?
|
| Incidence | 1 | 2019 | 1200 | 0.140 |
Why?
|
| Sus scrofa | 2 | 2015 | 46 | 0.130 |
Why?
|
| Treatment Outcome | 2 | 2021 | 3314 | 0.130 |
Why?
|
| Myostatin | 1 | 2015 | 3 | 0.130 |
Why?
|
| Rats, Sprague-Dawley | 2 | 2018 | 742 | 0.130 |
Why?
|
| Myogenic Regulatory Factors | 1 | 2015 | 8 | 0.130 |
Why?
|
| Emergency Service, Hospital | 1 | 2019 | 473 | 0.130 |
Why?
|
| Pulmonary Valve | 1 | 2015 | 11 | 0.130 |
Why?
|
| RNA Interference | 1 | 2015 | 76 | 0.130 |
Why?
|
| Cell Movement | 3 | 2019 | 169 | 0.130 |
Why?
|
| Glycoproteins | 1 | 2015 | 45 | 0.130 |
Why?
|
| Muscular Atrophy | 1 | 2015 | 71 | 0.130 |
Why?
|
| RNA, Small Interfering | 1 | 2015 | 114 | 0.130 |
Why?
|
| Prognosis | 1 | 2019 | 1505 | 0.130 |
Why?
|
| Myocardial Infarction | 1 | 2019 | 485 | 0.130 |
Why?
|
| Retrospective Studies | 2 | 2020 | 3523 | 0.130 |
Why?
|
| Risk Assessment | 1 | 2021 | 1434 | 0.130 |
Why?
|
| Heart Valve Prosthesis | 1 | 2015 | 55 | 0.120 |
Why?
|
| Peptides | 1 | 2015 | 119 | 0.120 |
Why?
|
| Adipogenesis | 2 | 2020 | 29 | 0.120 |
Why?
|
| PAX7 Transcription Factor | 1 | 2014 | 8 | 0.120 |
Why?
|
| Cell Division | 3 | 2004 | 95 | 0.120 |
Why?
|
| Gene Expression | 1 | 2015 | 333 | 0.120 |
Why?
|
| Cytoskeleton | 2 | 2013 | 18 | 0.120 |
Why?
|
| Down-Regulation | 1 | 2014 | 142 | 0.110 |
Why?
|
| Bioreactors | 2 | 2015 | 60 | 0.110 |
Why?
|
| Antibodies, Monoclonal | 1 | 2015 | 244 | 0.110 |
Why?
|
| Elastic Modulus | 3 | 2019 | 28 | 0.110 |
Why?
|
| Fiber Optic Technology | 1 | 2013 | 15 | 0.110 |
Why?
|
| MicroRNAs | 1 | 2015 | 180 | 0.110 |
Why?
|
| Poloxamer | 1 | 2013 | 4 | 0.110 |
Why?
|
| Carbocyanines | 1 | 2013 | 3 | 0.110 |
Why?
|
| Serum Albumin, Bovine | 1 | 2013 | 10 | 0.110 |
Why?
|
| Myoglobin | 1 | 2013 | 11 | 0.110 |
Why?
|
| Transplants | 1 | 2013 | 23 | 0.110 |
Why?
|
| Soft Tissue Injuries | 1 | 2013 | 20 | 0.110 |
Why?
|
| Receptors, Cholinergic | 1 | 2013 | 22 | 0.110 |
Why?
|
| Aged, 80 and over | 1 | 2021 | 3998 | 0.110 |
Why?
|
| Risk Factors | 1 | 2021 | 3867 | 0.110 |
Why?
|
| Injections | 1 | 2013 | 64 | 0.110 |
Why?
|
| Embryonic Stem Cells | 1 | 2013 | 28 | 0.110 |
Why?
|
| Fluorescent Dyes | 1 | 2013 | 48 | 0.110 |
Why?
|
| Enzymes, Immobilized | 1 | 2012 | 4 | 0.100 |
Why?
|
| Chondrogenesis | 1 | 2012 | 19 | 0.100 |
Why?
|
| 3T3 Cells | 3 | 2002 | 14 | 0.100 |
Why?
|
| Culture Media | 1 | 2012 | 47 | 0.100 |
Why?
|
| Pilot Projects | 3 | 2019 | 543 | 0.100 |
Why?
|
| Amines | 1 | 2012 | 22 | 0.100 |
Why?
|
| Endothelium, Vascular | 1 | 2013 | 156 | 0.100 |
Why?
|
| Mechanical Phenomena | 1 | 2012 | 28 | 0.100 |
Why?
|
| Cell Lineage | 1 | 2012 | 71 | 0.100 |
Why?
|
| Peripheral Nerves | 1 | 2012 | 62 | 0.100 |
Why?
|
| Neurosurgical Procedures | 1 | 2012 | 99 | 0.100 |
Why?
|
| Heart Valves | 1 | 2011 | 16 | 0.100 |
Why?
|
| Neurotransmitter Agents | 1 | 2011 | 26 | 0.100 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2011 | 24 | 0.100 |
Why?
|
| Mice, Inbred Strains | 1 | 2011 | 47 | 0.100 |
Why?
|
| Recovery of Function | 1 | 2013 | 200 | 0.100 |
Why?
|
| Chemotaxis | 1 | 2011 | 24 | 0.100 |
Why?
|
| Water | 2 | 2004 | 56 | 0.100 |
Why?
|
| Urinary Bladder | 2 | 2013 | 182 | 0.100 |
Why?
|
| Analysis of Variance | 1 | 2012 | 462 | 0.100 |
Why?
|
| Flow Cytometry | 1 | 2011 | 185 | 0.100 |
Why?
|
| Fibrinogen | 1 | 2010 | 44 | 0.090 |
Why?
|
| Neovascularization, Physiologic | 1 | 2011 | 110 | 0.090 |
Why?
|
| Hardness | 2 | 2015 | 5 | 0.090 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2013 | 1324 | 0.090 |
Why?
|
| Electrochemical Techniques | 1 | 2010 | 23 | 0.090 |
Why?
|
| Foreskin | 1 | 2009 | 8 | 0.080 |
Why?
|
| Tissue Culture Techniques | 1 | 2009 | 40 | 0.080 |
Why?
|
| Elastin | 2 | 2006 | 14 | 0.080 |
Why?
|
| Cell Count | 1 | 2008 | 47 | 0.080 |
Why?
|
| Compressive Strength | 2 | 2019 | 23 | 0.070 |
Why?
|
| Hemostatics | 1 | 2006 | 11 | 0.070 |
Why?
|
| Embryo, Mammalian | 1 | 2006 | 31 | 0.070 |
Why?
|
| Anterior Cruciate Ligament | 1 | 2006 | 42 | 0.070 |
Why?
|
| Prosthesis Implantation | 2 | 2016 | 40 | 0.060 |
Why?
|
| Cell Size | 1 | 2004 | 38 | 0.060 |
Why?
|
| Absorption | 1 | 2004 | 15 | 0.060 |
Why?
|
| Phenotype | 2 | 2016 | 631 | 0.060 |
Why?
|
| Epidermis | 1 | 2023 | 30 | 0.060 |
Why?
|
| Cell Separation | 2 | 2015 | 92 | 0.060 |
Why?
|
| Microscopy, Fluorescence | 2 | 2014 | 88 | 0.060 |
Why?
|
| Wettability | 1 | 2003 | 2 | 0.060 |
Why?
|
| PC12 Cells | 1 | 2003 | 6 | 0.060 |
Why?
|
| Electrodes | 1 | 2003 | 19 | 0.060 |
Why?
|
| Extracellular Matrix Proteins | 2 | 2013 | 45 | 0.050 |
Why?
|
| Pancreas | 1 | 2023 | 104 | 0.050 |
Why?
|
| Core Binding Factor Alpha 1 Subunit | 2 | 2012 | 7 | 0.050 |
Why?
|
| Carbonates | 1 | 2022 | 3 | 0.050 |
Why?
|
| Catalase | 1 | 2022 | 15 | 0.050 |
Why?
|
| Starch | 2 | 2012 | 8 | 0.050 |
Why?
|
| Biomedical Engineering | 2 | 2013 | 26 | 0.050 |
Why?
|
| Alkaline Phosphatase | 2 | 2012 | 38 | 0.050 |
Why?
|
| Peroxides | 1 | 2022 | 32 | 0.050 |
Why?
|
| Biodegradation, Environmental | 1 | 2002 | 4 | 0.050 |
Why?
|
| Models, Chemical | 1 | 2002 | 34 | 0.050 |
Why?
|
| Insulin | 1 | 2023 | 366 | 0.050 |
Why?
|
| Preoperative Period | 1 | 2020 | 35 | 0.050 |
Why?
|
| Calcium | 2 | 2013 | 307 | 0.050 |
Why?
|
| Fluorescent Antibody Technique | 2 | 2012 | 91 | 0.040 |
Why?
|
| Reference Values | 1 | 2020 | 247 | 0.040 |
Why?
|
| Keratinocytes | 1 | 2020 | 29 | 0.040 |
Why?
|
| Fibrosis | 1 | 2020 | 118 | 0.040 |
Why?
|
| Insulin-Like Growth Factor Binding Protein 3 | 1 | 2019 | 20 | 0.040 |
Why?
|
| Podocytes | 1 | 2019 | 20 | 0.040 |
Why?
|
| Cues | 1 | 2019 | 68 | 0.040 |
Why?
|
| Prosthesis Fitting | 1 | 2019 | 4 | 0.040 |
Why?
|
| Osteocytes | 1 | 2019 | 4 | 0.040 |
Why?
|
| Ischemia | 1 | 2020 | 98 | 0.040 |
Why?
|
| Membranes, Artificial | 1 | 1999 | 7 | 0.040 |
Why?
|
| X-Ray Microtomography | 1 | 2019 | 40 | 0.040 |
Why?
|
| Polyethylenes | 1 | 2018 | 2 | 0.040 |
Why?
|
| Prosthesis Design | 1 | 2019 | 97 | 0.040 |
Why?
|
| Esthetics | 1 | 2018 | 10 | 0.040 |
Why?
|
| Light | 1 | 2018 | 24 | 0.040 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2019 | 81 | 0.040 |
Why?
|
| Meiosis | 1 | 2016 | 33 | 0.030 |
Why?
|
| Rats, Inbred F344 | 1 | 2016 | 133 | 0.030 |
Why?
|
| Bronchoscopy | 1 | 2016 | 47 | 0.030 |
Why?
|
| Progesterone | 1 | 2016 | 95 | 0.030 |
Why?
|
| Oocytes | 1 | 2016 | 48 | 0.030 |
Why?
|
| Estradiol | 1 | 2016 | 128 | 0.030 |
Why?
|
| Mandible | 1 | 2016 | 39 | 0.030 |
Why?
|
| Cell-Free System | 1 | 2015 | 15 | 0.030 |
Why?
|
| Tissue Survival | 1 | 2015 | 12 | 0.030 |
Why?
|
| Solutions | 1 | 2015 | 36 | 0.030 |
Why?
|
| Urea | 1 | 2015 | 37 | 0.030 |
Why?
|
| Albumins | 1 | 2015 | 45 | 0.030 |
Why?
|
| Spheroids, Cellular | 1 | 2015 | 37 | 0.030 |
Why?
|
| Equipment Failure Analysis | 1 | 2015 | 43 | 0.030 |
Why?
|
| Polyethylene Glycols | 1 | 2015 | 64 | 0.030 |
Why?
|
| Stress, Mechanical | 1 | 2015 | 92 | 0.030 |
Why?
|
| Perfusion | 1 | 2015 | 73 | 0.030 |
Why?
|
| Equipment Design | 1 | 2015 | 172 | 0.030 |
Why?
|
| Intracellular Space | 1 | 2014 | 16 | 0.030 |
Why?
|
| Adenosine Triphosphate | 1 | 2014 | 53 | 0.030 |
Why?
|
| Adenosine | 1 | 2014 | 59 | 0.030 |
Why?
|
| Tenascin | 1 | 2013 | 5 | 0.030 |
Why?
|
| Collagen Type III | 1 | 2013 | 9 | 0.030 |
Why?
|
| Protein Transport | 1 | 2013 | 74 | 0.030 |
Why?
|
| Tendon Injuries | 1 | 2013 | 38 | 0.030 |
Why?
|
| Basic Helix-Loop-Helix Transcription Factors | 1 | 2013 | 46 | 0.030 |
Why?
|
| Sulfonic Acids | 1 | 2013 | 3 | 0.030 |
Why?
|
| Quaternary Ammonium Compounds | 1 | 2013 | 7 | 0.030 |
Why?
|
| Bis-Trimethylammonium Compounds | 1 | 2013 | 1 | 0.030 |
Why?
|
| Collagenases | 1 | 2013 | 9 | 0.030 |
Why?
|
| Agrin | 1 | 2013 | 8 | 0.030 |
Why?
|
| Infrared Rays | 1 | 2013 | 18 | 0.030 |
Why?
|
| Chick Embryo | 1 | 2013 | 74 | 0.030 |
Why?
|
| Mucous Membrane | 1 | 2013 | 20 | 0.030 |
Why?
|
| Muscle Denervation | 1 | 2013 | 29 | 0.030 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2013 | 27 | 0.030 |
Why?
|
| Tissue Distribution | 1 | 2013 | 60 | 0.030 |
Why?
|
| Apoptosis | 1 | 2015 | 352 | 0.030 |
Why?
|
| Acetylcholine | 1 | 2013 | 47 | 0.030 |
Why?
|
| Peroneal Nerve | 1 | 2012 | 15 | 0.030 |
Why?
|
| Calcification, Physiologic | 1 | 2012 | 8 | 0.030 |
Why?
|
| Axons | 1 | 2012 | 35 | 0.030 |
Why?
|
| Spectroscopy, Fourier Transform Infrared | 1 | 2012 | 4 | 0.030 |
Why?
|
| Sciatic Nerve | 1 | 2012 | 36 | 0.030 |
Why?
|
| Spectrometry, X-Ray Emission | 1 | 2012 | 3 | 0.030 |
Why?
|
| Anthraquinones | 1 | 2012 | 6 | 0.030 |
Why?
|
| Aggrecans | 1 | 2012 | 4 | 0.030 |
Why?
|
| Collagen Type II | 1 | 2012 | 8 | 0.030 |
Why?
|
| Sepharose | 1 | 2012 | 6 | 0.030 |
Why?
|
| Organ Specificity | 1 | 2012 | 80 | 0.030 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2013 | 132 | 0.030 |
Why?
|
| Staining and Labeling | 1 | 2012 | 60 | 0.030 |
Why?
|
| Biological Transport | 1 | 2011 | 69 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 493 | 0.020 |
Why?
|
| Octoxynol | 1 | 2009 | 6 | 0.020 |
Why?
|
| Platelet Adhesiveness | 1 | 2008 | 14 | 0.020 |
Why?
|
| Adult | 1 | 2020 | 9340 | 0.020 |
Why?
|
| Stifle | 1 | 2006 | 4 | 0.020 |
Why?
|
| Biological Dressings | 1 | 2006 | 1 | 0.020 |
Why?
|
| Occlusive Dressings | 1 | 2006 | 9 | 0.020 |
Why?
|
| Bandages | 1 | 2006 | 33 | 0.020 |
Why?
|
| Shear Strength | 1 | 2005 | 9 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2006 | 628 | 0.010 |
Why?
|
| Carbon | 1 | 1999 | 12 | 0.010 |
Why?
|
| Oxidation-Reduction | 1 | 1999 | 268 | 0.010 |
Why?
|